Skip to main content
SpringerLink
Log in

Invasiveness of transformed bladder epithelial cells

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

The invasiveness of bladder tumors has been studied in man, experimental animals, and in tissue culture by numerous authors.

The prognostic importance of cellular markers for invasiveness is stressed, and the usefulness of histopathological and cytologic grading, cytogenetic studies, antigenic investigations, and enzymatic characterization is discussed.

The invasiveness of bladder cells has frequently been examined in transplantation and explantation experiments. In human urothelial cell cultures three grades of transformation are defined, and a correlation has been established between the invasiveness of these cell lines in a three-dimensional in vitro model and their tumorigenicity in nude mice.

The mechanism of tumor invasion is discussed, and it is recommended in future research to make a distinction between invasion en bloc and cellular infiltration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bergkvist A, Ljungquist A, Moberger M: Classification of bladder tumours based on the cellular pattern—preliminary report of a clinical pathological study of 300 cases with a minimum follow up of eight years. Acta Chir Scand 130: 371–378, 1965.

    Google Scholar 

  2. Friedell GH, Nagy GK, Cohen SM: Pathology of human bladder cancer and related lesions. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 1. CRC Press, Inc, Boca Raton, Florida, 1983, pp 11–42.

    Google Scholar 

  3. Eisenberg RB, Roth RB, Schweinsberg MH: Bladder tumors and associated proliferative mucosal lesions. J Urol 84: 544–550, 1960.

    Google Scholar 

  4. Andersen JA, Hansen BF: The incidence of cell nests, cystitis cystica and cystitis glandularis in the lower urinary tract revealed by autopsies. J Urol 108: 421–424, 1972.

    Google Scholar 

  5. Ito N, Hirose M, Shirai T, Tsuda H, Nakarishi K, Fukushima S: Lesions of the urinary bladder epithelium in 125 autopsy cases. Acta Pathol Jpn 31: 545–557, 1981.

    Google Scholar 

  6. Wiener DP, Koss LG, Sablay B, Freed SZ: The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. J Urol 122: 317–321, 1979.

    Google Scholar 

  7. Cohen SM: Pathology of experimental bladder cancer in rodents. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 2. CRC Press, Inc, Boca Raton, Florida, 1983, pp 1–40.

    Google Scholar 

  8. Farrow GM, Utz DC: Carcinoma in situ. Ibid, Vol 1, pp 43–56.

  9. Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lonni YW, Rowe JH, Cooper JF, Nussbaum H, Chan P, Rao A, Starr A: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J Urol 119: 488–492, 1978.

    Google Scholar 

  10. Pyrah LN, Raper FP, Thomas GM: Report of a follow-up of papillary tumours of the bladder. Br J Urol 36: 14–25. 1964.

    Google Scholar 

  11. Lund F, Lundwall F: Bl≸repapillomer. En analyse og efterundersøgelse af 183 tilf≸lde. Ugeskr L≸ger 117: 1123–1131, 1955.

    Google Scholar 

  12. Kaye KW, Lange PH: Mode of presentation of invasive bladder cancer: Reassessment of the problem. J Urol 128: 31–33, 1982.

    Google Scholar 

  13. Brawn PN: The origin of invasive carcinoma of the bladder. Cancer 50: 515–519, 1982.

    Google Scholar 

  14. Koss LG, Melamed MR, Kelly RE: Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: Progress report. JNCI 43: 233–243, 1969.

    Google Scholar 

  15. Farrow GM, Utz DC, Rife CC, Greene LF: Clinical observation on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 37: 2794–2798, 1977.

    Google Scholar 

  16. Harmer MH (ed): TNM classification of malignant tumours. UICC, Geneva, 1978.

    Google Scholar 

  17. Prout GRJr: Bladder carcinoma and a TNM system of classification. J Urol 117: 583–590, 1977.

    Google Scholar 

  18. Anderstroem C, Johansson S, Nilsson S: The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 124: 23–26, 1980.

    Google Scholar 

  19. Steg A, Allouch G, Deslignières S: Les facteurs de risque des tumeurs de vessie au stade A. Description d'un nouveau paramètre. Sem Hop Paris 56: 738–743, 1980.

    Google Scholar 

  20. Urinbæretumorer. Betænkning fra Dansk Urologisk Selskabs blærecancerudvalg af 1978. Ugeskr Læger 144: 1063–1074, 1982.

    Google Scholar 

  21. Hart IR, Fidler IJ: The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 651: 37–50, 1981.

    Google Scholar 

  22. Fidler IJ: Tumor heterogeneity and the histology of cancer invasion and metastasis. Cancer Res 38: 2651–2660, 1978.

    Google Scholar 

  23. Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149–250. 1978.

    Google Scholar 

  24. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139–145, 1980.

    Google Scholar 

  25. Farber E, Cameron R: The sequential analysis of cancer development. Adv Cancer Res 31: 125–226, 1980.

    Google Scholar 

  26. Bryan GT: Etiology and pathogenesis of bladder cancer. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 1. CRC Press, Inc, Boca Raton, Florida, 1983, pp 1–9.

    Google Scholar 

  27. Hicks RM, Chowaniec J: Experimental induction, histology, and ultrastructure of hyperplasia and neoplasis of the urinary bladder epithelium. Int Rev Exp Pathol 18: 199–280, 1978.

    Google Scholar 

  28. Kunze E: Development of urinary bladder cancer in the rat. In: Grundman E (ed) Carcinogenesis. Current topics in pathology 67. Springer, Berlin, 1979, pp 142–163.

    Google Scholar 

  29. Cohen SM, Greenfield RE, Ellwein LB: Multistage carcinogenesis in the urinary bladder. Environ Health Perspects 49: 209–215, 1983.

    Google Scholar 

  30. Friedell GH, Bell JR, Burney SW, Soto EA, Tiltman AJ: Histopathology and classification of urinary bladder carcinoma. Urol Clin North Am 3: 53–70, 1976.

    Google Scholar 

  31. Mostofi FK, Sobin LH, Torloni H: Histological typing of urinary bladder tumors. World Health Organization, Geneva, 1973.

    Google Scholar 

  32. Helpap B, Giesbert A: Grading und Staging von urothelialen Harnblasen Carcinom. Dtsch Med Wochenschr 107: 1274–1279, 1982.

    Google Scholar 

  33. Morrison AS, Proppe KH, Verhock WG, Aoki K, Lech I, Ohno Y, Obata K: Histologic characteristics of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. Int J Cancer 15: 701–705, 1982.

    Google Scholar 

  34. Fukushima S, Hirose M, Tsuda H, Shirai T, Hirao K, Arai M, Ito N: Histological classification of urinary bladder cancers in rats induced by N-butyl-N-(4 hydroxybutyl) nitrosamine. Gann 67: 81–90, 1976.

    Google Scholar 

  35. Barlebo H, Sørensen BL, Søeborg Ohlsen A: Carcinoma in situ of the urinary bladder: flat intraepithelial neoplasia. Scand J Urol 6: 213–223, 1972.

    Google Scholar 

  36. King EB: Cytology of bladder cancer. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 1. CRC Press, Inc, Boca Raton, Florida, 1983, pp 91–151.

    Google Scholar 

  37. Kern WH: The cytology of transitional cell carcinoma of the urinary bladder. Acta Cytol 19: 420–428, 1975.

    Google Scholar 

  38. Graham SD, Lender JJ, Woodard BH, Paulson DF: The value of cellular morphometrics in low stage carcinoma of the bladder (Abstract). 78th Ann Meeting Am Urol Assoc, Las Vegas, 1983. Am Urol Assoc, Inc, 1983, p 330.

  39. Kieler J, Ostrowski K, Strojny P, Dziedzic-Goclawska A, Bulski W: Fourier analysis of transformed human urothelial cells in vitro. Histochemistry. In press.

  40. Shigematsu S: Significance of the chromosome in vesicle cancer. Proc XII Cong Soc Int Urologie, London, 1965, pp 11–121.

  41. Lamb D: Correlation of chromosome counts with histological appearances and prognosis of transitional cell carcinoma of the bladder. Br Med J 1: 273–277, 1967.

    Google Scholar 

  42. Spooner MR, Cooper EH: Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer 29: 1401–1412, 1972.

    Google Scholar 

  43. Levi PE, Cooper EH, Anderson CK, Williams RE: Analysis of DNA content nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer 23: 1074–1085, 1969.

    Google Scholar 

  44. Cooper EH, Levi PE, Anderson CK, Williams RE: The evolution of tumour cell populations in human bladder cancer. Br J Urol 41: 714–717, 1969.

    Google Scholar 

  45. Vilien M, Christensen B, Wolf H, Rasmussen F, Hou-Jensen C, Povlsen CO: Comparative studies of normal, ‘spontaneously’ transformed and malignant human urothelium cells in vitro. Eur J Cancer Clin Oncol 19: 775–789, 1983.

    Google Scholar 

  46. Christensen B, Kieler J, Vilien M, Don P, Wang CY, Wolf H: A classification of human urothelial cells propagated in vitro. To be published.

  47. Javadpour N, Roy JB, Bottomlay R, Dagy K: Combined cell surface antigens and chromosomal studies in bladder cancer. Urology 19: 29–32, 1982.

    Google Scholar 

  48. Martorana G, Giberti C, de Ferrari M, Calvi P, Ottagio L, Pescatore D: Cytogenetic analysis of transitional cell carcinoma of the bladder. Clinical implications. Eur Urol 9: 28–31, 1983.

    Google Scholar 

  49. Sandberg AA: Chromosome markers and progression in bladder cancer. Cancer Res 37: 2950–2956, 1977.

    Google Scholar 

  50. Falor WH, Ward RM: Prognosis in early carcinoma of the bladder based on chromosome analysis. J Urol 119: 44–48, 1978.

    Google Scholar 

  51. Falor WH, Ward RM: Cytogenetics of bladder carcinoma: A key to prognosis in non-invasive and submucosal invasive carcinoma. Cancer Detect Prevent 4: 449–453, 1981.

    Google Scholar 

  52. Sandberg AA: Chromosomes in human bladder tumors (Abstract). Advances in Bladder Cancer Research, Saratosa, 1983. National Bladder Cancer Projects, 1983, p 112.

  53. Hastings RJ, Franks LM: Chromosome pattern, growth in agar and tumorigenicity in nude mice of four human bladder carcinoma cell lines. Int J Cancer 27: 15–21, 1981.

    Google Scholar 

  54. Jautzke G, Altenaehr E: Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas. Cancer 50: 2052–2056, 1982.

    Google Scholar 

  55. Vilien M, Wolf H, Rasmussen F: Immunological characterization of cell lines established from malignant and normal human urothelium. Eur J Cancer 17: 321–327, 1981.

    Google Scholar 

  56. Bubenik J, Kieler J, Christensen B: Monoclonal antibodies directed against determinants of human urinary bladder carcinoma cells. Specificity and distribution of epitopes. In: Kieler J and Ulrich K (eds) Annual Report 1983 from the Fibiger Institute, Copenhagen, 1984, pp 58–59.

  57. Pocock RD, Ibrahim SK, Sloane JP, Pinder BA, Shearer RJ: Potential value of epithelial membrane antigen in detecting early invasion in transitional cell carcinoma. Br J Urol 55: 670–675, 1983.

    Google Scholar 

  58. Jacobsen F: Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional cell tumors of the urinary bladder. Acta Pathol Microbiol Scand C 89: 235–239, 1981.

    Google Scholar 

  59. Jacobsen F: Complement-dependent in vitro cytotoxicity against autologous invasive bladder tumor cells in humans. Evaluation of the possible role of naturally occurring antibodies in complement-dependent cytotoxicity. Acta Pathol Microbiol Scand C 89: 297–302, 1981.

    Google Scholar 

  60. Weinstein RS, Alroy J, Farrow GM, Miller AWIII, Davidsohn I: Blood group isoantigen deletion in carcinoma in situ of the urinary bladder. Cancer 43: 661–668, 1979.

    Google Scholar 

  61. Alroy J, Miller AWIII, Coon JS, James KK, Gould VE: Inverted papilloma of the urinary bladder: Ultrastructural and immunologic studies. Cancer 46: 64–70, 1980.

    Google Scholar 

  62. Pauli BU, Alroy J, Weinstein RS: The ultrastructure and pathology of urinary bladder cancer. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 2. CRC Press, Inc, Boca Raton, Florida, 1983, pp 41–140.

    Google Scholar 

  63. Kay HEM, Wallace DM: A and B antigens of tumors arising from urinary epithelium. J Natl Cancer Inst 26: 1349–1365, 1961.

    Google Scholar 

  64. Emmott RC, Javadpour N, Bergman SM, Soares T: Correlation of the cell surface antigens with stage and grade in cancer of the bladder. J Urol 121: 37–39, 1979.

    Google Scholar 

  65. Kumon H, Ahahi T, Morioka M, Matsumura Y, Ohmori H: Isoantigens ABH in bladder tumors as an indicator of malignant potential. Nippon Hinyokika Gakkai Zasshi 71: 767–774, 1980.

    Google Scholar 

  66. Richie JP, Blute RD, Waisman J: Immunologic indicators of prognosis in bladder cancer. The importance of cell surface antigens. J Urol 123: 22–24, 1980.

    Google Scholar 

  67. Fujita J, Matsumoto K, Kishi K, Ishiyama I: Synthesis of ABH blood group substances in bladder tumours. Br J Urol 53: 448–452, 1981.

    Google Scholar 

  68. Catalona WJ: Practical utility of specific red cell adherence test in bladder cancer. Urology 18, 113–117, 1981.

    Google Scholar 

  69. Stein BS, Kendall AR: Blood group antigens and bladder carcinoma: A perspective. Urology 20: 229–233, 1982.

    Google Scholar 

  70. Alroy J, Teramura K, Miller AWIII, Pauli BU, Gottesman JE, Flanagan M, Davidsohn I, Weinstein RS: Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy. Cancer 41: 1739–1745, 1978.

    Google Scholar 

  71. Limas C, Lange P: Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. Cancer 46: 1366–1373, 1980.

    Google Scholar 

  72. Flanigan RC, King CT, Clark TD, Cash JB, Greenfield BJ, Sniecinski IJ, Primus FJ: Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium. A comparison with standard red cell adherence. J Urol 130: 499–503, 1983.

    Google Scholar 

  73. Coon JS, Weinstein RS: Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am J Clin Pathol 76: 163–171, 1981.

    Google Scholar 

  74. Finan PJ, Anderson JR, Doyle PT, Lennox ES, Bleehen NM: The prediction of invasive potential in superficial transitional cell carcinoma of the bladder. Br J Urol 54: 720–725, 1982.

    Google Scholar 

  75. Javadpour N, Vafier J, O'Connel K: A double blind comparison of T-antigen and ABO (H) cell surface antigens in bladder cancer (Abstract). 78th Ann Meeting Am Urol Assoc, Las Vegas, 1983. Am Urol Assoc, Inc, 1983, p 330.

  76. Rouger P, Vallancier G, Léclerc JP, Gane P, Salmon C: Distribution des Antigenés, A.B.H, dans les tumeurs de la vessie. Etude rétrospective par immunofluorescence. Nouv Presse Med 11: 419–421, 1982.

    Google Scholar 

  77. Vacant J, Le Portz B, Augustin I, Hammou JC, Fella C, Délignières S, Maioloni R, Masseyeff R, Abelanet R, Steg A: Les antigénes de groupe sanguin ABO(H), dans les tumeurs de vessie infiltrant le chorion. Valeur pronostique de leur détermination par immunofluorescence. Etude rétrospective de cent vingt-cinq cas. Ann Urol (Paris) 16: 24–29, 1982.

    Google Scholar 

  78. Raymond G, Hammou H, Fella C, Toubol J, Pastorini P, Masseyef R: Une nouvelle technique de détection des antigenes A, B, H dans les tumeurs de vessie. Incidence prognostique. Ann Urol (Paris) 15: 329–332, 1981.

    Google Scholar 

  79. Young AK, Hammond E, Middleton AWJr: The prognostic value of cell surface antigens in low grade, noninvasive, transitional cell carcinomas of the bladder. J Urol 122: 462–464, 1979.

    Google Scholar 

  80. Jakse G, Hofstädter F: ABH-Antigenität beim Blasentumor. Helv Chir Acta 45: 313–316, 1978.

    Google Scholar 

  81. Decenzo JM, Howard P, Irish CE: Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinomas. J Urol 114: 874–878, 1975.

    Google Scholar 

  82. Berwick L, Coman DR: Some chemical factors in cellular adhesion and stickiness. Cancer Res 22: 982–986, 1962.

    Google Scholar 

  83. Stiller D, Rauscher H: Irreversible preneoplastic defect in alkaline phosphatase in cancerization of transitional epithelium. Exp Pathol 5: 255–258, 1971.

    Google Scholar 

  84. Clayson DB, Cooper EH: The immediate response of bladder epithelium to injury by chemical carcinogens. Brit J Urol 41: 710–713, 1969.

    Google Scholar 

  85. Highman B, Frith CH, Littlefield NA: Sequential alkaline phosphatase changes in hyperplastic and neoplastic urothelium of mice fed 2-acetylaminofluorene. Environ Pathol Toxicol 1: 223–231, 1978.

    Google Scholar 

  86. Kabat EA, Furth J: A histochemical study of the distribution of alkaline phosphatase in various normal and neoplastic tissues. Am J Pathol 17: 303–318, 1941.

    Google Scholar 

  87. Cohen SM, Athans J: See Cohen SM: Pathology of experimental bladder cancer in rodents. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 2. CRC Press, Inc, Boca Raton, Florida, 1983, pp 1–40.

    Google Scholar 

  88. Lavin P, Koss LG: Studies of experimental bladder carcinoma in Fischer 344 female rats. II. Characterization of 3 cell lines derived from induced urinary bladder carcinomas. JNCI 46: 597–614, 1971.

    Google Scholar 

  89. Wilson PD, Summerhayes IC, Franks LM: Alkaline phosphatase as a marker of transformation in adult mouse bladder epithelium after in vitro exposure to 7,12-dimethyl(a)benz-anthracene. Cell Biol Int Rep 2: 365–374, 1978.

    Google Scholar 

  90. Wilson PD, Hodges GM: Focal distribution of surface marker enzymes after long term culture of adult rat bladder epithelium and methylnitrosourea (MNU)-induced bladder tumors. J Histochem Cytochem 27: 1236–1246, 1979.

    Google Scholar 

  91. Wilson PD, Benham F, Franks LM: Alkaline phosphatase phenotypes in tumour and nontumour cell lines: Not an invariable marker for neoplastic transformation. Cell Biol Int Rep 1: 229–238, 1977.

    Google Scholar 

  92. Hack MH, Helmy FM, Chaiban RC: Some histochemical and lipid chromatographic observations on human urinary bladder carcinoma. Ann Histochim 19: 73–76, 1974.

    Google Scholar 

  93. El-Houssini ME, Christensen B, Wolf H, Kieler J: Alkaline and acid phosphatase and NADH-diaphorase activities in explanted human urothelium. To be published.

  94. Hepburn PJ, Masters RW: The biological characteristics of continuous cell lines derived from human bladder. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer. Vol 2. CRC Press, Inc, Boca Raton, Florida, 1983, pp 213–227.

    Google Scholar 

  95. Herz F, Barlebo H, Koss LG: Modulation of alkaline phosphatase activity in cell cultures derived from human urinary bladder carcinoma. Cancer Res 34: 1943–1946, 1974.

    Google Scholar 

  96. Benham F, Cotell DC, Franks LM, Wilson PD: Alkaline phosphatase activity in human bladder tumor cell lines. J Histochem Cytochem 25: 266–274, 1977.

    Google Scholar 

  97. Herz F, Koss LG: Alkaline phosphatase activity in cultured urinary bladder cancer cells. Arch Biochem Biophys 194: 30–36, 1979.

    Google Scholar 

  98. Hisazumi H, Andersson L, Collins VP: Fibrinolytic activity of in vitro cultivated human bladder cell lines. Urol Res 5: 133–139, 1977.

    Google Scholar 

  99. Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Hayata Y, Yasumoto K: Thromboplastic and fibrinolytic activities of cultured human cell lines. Br J Cancer 39: 15–23, 1979.

    Google Scholar 

  100. Wirl G: Kollagenaseaktivität in einem tierischen und einem menschlichen Karzinom. Wien Klin Wochenschrift 89: 766–768, 1977.

    Google Scholar 

  101. Kunit G, Wirl G, Frick J: Collagenase activity in human bladder cancers. In: Pavone-Macaluso M, Smith PH, Edsmyr F (eds) Bladder tumors and other topics in urological oncology, Vol 1. Plenum Press, Ettore Majorana International Science Series (Life Sciences), New York, 1980, p 528.

    Google Scholar 

  102. Hohberger LH, Arsenis C, Kuettner KE, Schwartz DE, Pauli BU: Multiple collagenolytic activities isolated from rat tumors and tumor cell cultures (Abstract). Fed Proc 42: 773, 1983.

    Google Scholar 

  103. Franks LM: Tissue culture and transplantation of bladder. In: Bryan GT and Cohen SM (eds) The pathology of bladder cancer, Vol 2. CRC Press, Inc, Boca Raton, Florida, 1983, pp 183–212.

    Google Scholar 

  104. Ertürk E, Cohen SM, Price YM, Bryan GT: Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res 29: 2219–2228, 1969.

    Google Scholar 

  105. Kaufman JJ, Kaneshiro W, Roux F: Further studies on human bladder and kidney tumors transplanted to the hamster cheek pouch. J Urol 101: 559–566, 1969.

    Google Scholar 

  106. Franks CR, Turner DR, Bishop D, Perkins FT: Growth characteristics of human bladder tumour subcutaneously implanted in immunodeficient mice. Clin Oncol 2: 25–32, 1976.

    Google Scholar 

  107. Berenbaum MC, Sheard CE, Reittie JR, Bundick RV: The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer 30: 13–32, 1974.

    Google Scholar 

  108. Sufrin G, McGarry MP, Sandberg AA, Murphy GP: Heterotransplantation of human transitional cell carcinoma in athymic mice. J Urol 121: 159–161, 1979.

    Google Scholar 

  109. Wunderli H, Mickey DD, Paulson DF: C-type virus particles in human urogenital tumours after heterotransplantation into nude mice. Br J Cancer 39: 35–42, 1979.

    Google Scholar 

  110. Kuga N, Yoshida K, Seido T, Oboshi S, Koide T, Shimosata Y, Nomura T: Heterotransplantation of cultured human cancer cells and human cancer tissues into nude mice. Gann 66: 547–560, 1975.

    Google Scholar 

  111. Don P, Kieler J: Cultivation of human bladder epithelial cells and studies of their invasiveness in vitro as a criterion of malignant alteration. In: Letnansky K (ed) Biology of the cancer cell — Proc V Meeting of European Assoc Cancer Res, Vienna 1979. Kugler Publications, Amsterdam, 1980, pp 327–346.

    Google Scholar 

  112. Poste G, Doll J, Hart IR, Fidler IJ: In vitro selection of murine B16 melanoma variants with enhanced tissue invasive properties. Cancer Res 40: 1636–1644, 1980.

    Google Scholar 

  113. Folkman J: Tumor angiogenesis. Adv Cancer Res 19: 331–358, 1974.

    Google Scholar 

  114. Folkman J, Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16: 207–248, 1976.

    Google Scholar 

  115. Gimbrone MA, Leapman SB, Cotran RS, Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136, 261–276, 1972.

    Google Scholar 

  116. Chodak GW, Haudenschild C, Gittes RF, Folkman J: Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 192: 762–771, 1980.

    Google Scholar 

  117. Tatematsu M, Cohen SM, Fukushima S, Shirai T, Shinohara Y, Ito N: Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography. Cancer Res 38: 1792–1800, 1978.

    Google Scholar 

  118. Cohen SM, Tatematsu M, Shinohara Y, Nakanishi K, Ito N: Neovascularization in rats during urinary bladder carcinogenesis induced by N-4-(5-nitro-2-furyl)-2-thiazolyl formamide. JNCI 65: 145–148, 1980.

    Google Scholar 

  119. Koo CH, Pauli BU, Cohen SM, Weinstein RS: Angiogenesis during early stages of chemical carcinogenesis of rat bladder epithelium (Abstract). 64th Ann Meeting, Anaheim, 1980. Fed Proc 39: 641, 1980.

    Google Scholar 

  120. Gimbrone MAJr, Gullino PM: Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. JNCI 56: 305–318, 1976.

    Google Scholar 

  121. Gullino PM: Natural history of breast cancer. Progression from hyperplasia to neoplasis a predicted by angiogenesis. Cancer 39: 2697–2703, 1977.

    Google Scholar 

  122. Gullino PM: Angiogenesis and oncogenesis. JNCI 61: 639–643, 1978.

    Google Scholar 

  123. Brem SS, Jensen HM, Gullino PM: Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41: 239–244, 1978.

    Google Scholar 

  124. Ziche M, Gullino PM: Angiogenesis and neoplastic progression in vitro. JNCI 69: 483–487, 1982.

    Google Scholar 

  125. Kaminski MJ, Kieler J, Christensen B: Angiogenesis-inducing ability of human bladder epithelium cell lines and ‘spontaneously’ transformed murine fibroblasts. Proc Soc Exp Biol Med 174: 383–391, 1983.

    Google Scholar 

  126. Kaminski M, Kaminska G, Jakobisiak M, Brezinski W: Inhibition of lymphocyte-induced angiogenesis by isolated chondrocytes. Nature 268: 238–240, 1977.

    Google Scholar 

  127. Kaminski M, Kaminska G, Majewski S: Inhibition of new blood vessel formation in mice by systemic administration of human rib cartilage extract. Experientia 34: 490–491, 1978.

    Google Scholar 

  128. Kumar S: Angiogenesis and antiangiogenesis. JNCI 64: 683–688, 1980.

    Google Scholar 

  129. Nicosia RF, Tchao R, Leighton J: Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res 43: 2159–2166, 1983.

    Google Scholar 

  130. Kieler J: Tumor cell invasion in vitro. Mühlbock Memorial Lecture. Proceedings Sixth Meeting of the European Association for Cancer Research, Budapest 1981. Kugler Publications, Amsterdam, 1982, pp 7–23.

    Google Scholar 

  131. Mareel MM: Recent aspects of tumor invasiveness. Int Rev Exp Pathol 22: 65–129, 1980.

    Google Scholar 

  132. Pauli BU, Anderson SN, Memoli VA, Kuettner KE: Development of an in vitro and in vivo epithelial tumor model for the study of invasion. Cancer Res 40: 4571–4580, 1980.

    Google Scholar 

  133. Pauli BU, Memoli VA, Kuettner KE: In vitro determination of tumor invasiveness using extracted hyaline cartilage. Cancer Res 41: 2084–2091, 1981.

    Google Scholar 

  134. Bracke ME, Van Cauwenberge RML, Mareel MM: Interaction of malignant cells with salt-extracted cartilage in vitro. Cancer Res 44: 297–304, 1984.

    Google Scholar 

  135. Don P, Kieler J, Vilien M: In vitro studies of the invasiveness of cultured malignant, ‘spontaneously’ transformed and normal human bladder cells. In: De Brabander M, Mareel MM, De Ridder L (eds) Cell movement and neoplasia. Pergamon Press, Oxford, 1980, pp 121–130.

    Google Scholar 

  136. Schroyens W, Mareel MM, Dragonetti C: In vitro invasiveness of human bladder cancer from cell lines and biopsy specimens. Clin Exp Metastasis 1: 153–162, 1983.

    Google Scholar 

  137. Mareel MM, Kint J, Meyvisch C: Methods of study of the invasion of malignant C3H-mouse fibroblasts into embryonic chick heart in vitro. Virchows Arch B. Cell Pathol 30: 95–111, 1979.

    Google Scholar 

  138. Mareel MM, Bruyneel E, Storme G: Attachment of mouse fibrosarcoma cells to precultured fragments of embryonic chick heart. An early step to invasion in vitro. Virchows Arch, Cell Pathol 34: 85–97, 1980.

    Google Scholar 

  139. Kieler J, Briand P, Van Peteghem MC, Mareel MM: Comparative studies of two types of ‘spontaneous’ malignant alteration of ST/a mouse lung fibroblasts propagated in vitro. In Vitro 5: 758–771, 1979.

    Google Scholar 

  140. Kieler J, Oda Y, Tokuriki Y: In vitro development of tumorigenic and invasive properties in cells initiated by ethylnitrosourea (ENU) in utero (Abstract). Seventh Meeting of the European Association for Cancer Research, Copenhangen, 1983. Eur J Cancer Clin Oncol 19: 1294, 1983.

    Google Scholar 

  141. DiStefano JF, Beck G, Zucker S: Cancer cell membrane proteases in invasion and normal cell destruction (Abstract). Proc Am Assoc Cancer Res 24: 106, 1983.

    Google Scholar 

  142. Schleich A, Tchao R, Frick M, Mayer A: Interaction of human carcinoma cells with an epithelial layer and the underlying basement membrane. Arch. Geschwulst-forsch 51: 40–44, 1981.

    Google Scholar 

  143. Nemec R, Pauli BU: Tumorigenicity assay for transformed cells in vitro (Abstract). Fed Proc 42: 518, 1983.

    Google Scholar 

  144. Straüli P, Barrett AJ, Baici A (eds): Proteinases and tumor invasion. EORTC Monograph Series, Vol 6. Raven Press, New York, 1980, pp 215.

    Google Scholar 

  145. Young JS, Lumsden CE, Stalker AL: The significance of the ‘tissue pressure’ of normal testicular and of neoplastic (Brown-Pearce Carcinoma) tissue in the rabbit. J Pathol Bacteriol 62: 313–333, 1950.

    Google Scholar 

  146. Eaves G: The invasive growth of malignant tumors as a purely mechanical process. J Pathol 109: 233–237, 1973.

    Google Scholar 

  147. Yokokawa M, Fukui I, Sekine H: Problems in urinary bladder cancer in the aged. Gan No Rinsho 29: 1151–1154, 1983.

    Google Scholar 

  148. Mareel MMK: The use of embryo organ cultures to study invasion in vitro. In: Liotta LA, Hart IR (eds) Tumor invasion and metastasis. Martinus Nijhoff Publishers, The Hague, Boston, London, 1982, pp 207–230.

    Google Scholar 

  149. Mareel M, De Brabander M: Methyl (5–2(2-thienylcarbonyl)-1H-benzimidazole-2-yl) carbamate, (R17934), a synthetic microtubule inhibitor, prevents malignant invasion in vitro. Oncology 35: 5–7, 1978.

    Google Scholar 

  150. Mareel M, De Brabander M: Effect of microtubule inhibitors on malignant invasion in vitro. JNCI 61: 787–792, 1978.

    Google Scholar 

  151. Storme G, Mareel M: Effect of anticancer agents on directional migration of malignant C3H mouse fibroblastic cells in vitro. Cancer Res 40: 943–948, 1980.

    Google Scholar 

  152. Storme G, Mareel M: Influence of anticancer agents on growth, migration and invasion of malignant fibroblastic cells. In: De Brabander M, Mareel M and De Ridder L (eds) Cell movement and neoplasia. Pergamon Press, Oxford, 1980, pp 103–109.

    Google Scholar 

  153. Storme G, Mareel M: Effect at anticancer agents on invasion of mouse fibrosarcoma cells in vitro. Oncology 38: 182–186, 1981.

    Google Scholar 

  154. Sträuli P, Weiss L: Cell locomotion and tumor penetration. Eur J Cancer 13: 1–12, 1977.

    Google Scholar 

  155. Pauli BU, Cohen SM, Alroy J, Weinstein RS: Desmosome ultrastructure and the biological behavior of chemical carcinogen-induced urinary bladder carcinomas. Cancer Res 38: 3276–3285, 1978.

    Google Scholar 

  156. Alroy J, Pauli BU, Weinstein RS: Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder. Cancer 47: 104–112, 1981.

    Google Scholar 

  157. Szende B, Kieler J, Lapis K, Christensen B: TEM and SEM studies of human bladder carcinoma cells invading chick heart fragments in vitro. (Abstract). Seventh Meeting of the European Association for Cancer Research, Copenhagen, 1983. Eur J Cancer Clin Oncol 19: 1318, 1983.

    Google Scholar 

  158. Alroy J, Gould VE: Epithelial-stromal interface in normal and neoplastic human bladder epithelium. Ultrastruct Pathol 1: 201–210, 1980.

    Google Scholar 

  159. Tickle C, Crawley A, Goodman M: Cell movement and the mechanism of invasiveness: A survey of the behaviour of some normal and malignant cells implanted into the developing chick wing bud. J Cell Sci 31: 293–322, 1978.

    Google Scholar 

  160. Tickle C, Crawley A, Goodman M: Mechanism of invasiveness of epithelial tumours: Ultrastructure of the interactions of carcinoma cells with embryonic mesenchyme and epithelium. J Cell Sci 33: 133–155, 1978.

    Google Scholar 

  161. Hayashi H, Yoshida K, Ozaki T, Ushijima K: Chemotatic factor associated with invasion of cancer cells. Nature 226: 174–175, 1970.

    Google Scholar 

  162. Mareel M, Kieler J, Van Cauwenberge R: Loss of directional migration after round-cell transformation of malignant ST/a mouse lung cells. Cell Biol Int Rep 5: 921–928, 1981.

    Google Scholar 

  163. Baba S, Shinmei M, Nakamura H, Koyama Y, Tazaki H: Hyaluronate and invasiveness of bladder carcinoma. (Abstract). 78th Ann Meeting Am Urol Assoc, Las Vegas, 1983. Am Urol Assoc, Inc, 1983, p 330.

  164. Martinez-Pineiro JA, Pertusa C, Maganto E, Zancajo VG, Magallon M, Losado G, Ortega F: Urinary fibrinogen degradation products (FDP) in bladder cancer. Eur Urol 4: 348–350, 1978.

    Google Scholar 

  165. Alsabti EA: Prognostic value of urinary fibrinogen degradation products in bladder carcinoma. Eur Surg Res 11: 185–190, 1979.

    Google Scholar 

  166. Kefalides NA, Alper R, Clark CC: Biochemistry and metabolism of basement membrane. Int Rev Cytol 61: 167–228, 1979.

    Google Scholar 

  167. Bornstein P, Sage H: Structurally distinct collagen types. Ann Rev Biochem 49: 957–1003, 1980.

    Google Scholar 

  168. McNutt NS: Ultrastructural comparison of the interface between epithelium and stroma in basal cell carcinoma and control human skin. Lab Invest 35: 132–142, 1976.

    Google Scholar 

  169. Liotta LA, Abe A, Robey PG, Martin GR: Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci 76: 2268–2272, 1979.

    Google Scholar 

  170. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators and cancer. Adv Cancer Res, in Press.

  171. Christman JK: Multiple forms of plasminogen activator. In: Ruddon RW (ed) Biological markers of neoplastic: basic and applied aspects. Elsevier/North Holland, The Netherlands, 1978, pp 433–449.

    Google Scholar 

  172. Larson L-I, Skriver L, Nielsen LS, Grøndahl-Hansen J, Kristensen P, Danø K: Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98: 894–903, 1984.

    Google Scholar 

  173. Skriver L, Larsson L-I, Kielberg V, Nielsen LS, Andresen PB, Kristensen P, Danø K: Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol, in press.

  174. Werb Z, Mainardi CL, Vater CA, Harris ED: Endogenous activation of latent collagenase by rheumatoid synovial cells. New Engl J Med 296: 1017–1023, 1977.

    Google Scholar 

  175. Moscatelli D, Rifkin DB, Isseroff RR, Jaffe EA: Plasminogen activator, plasmin and collagenase interactions. In: Sträuli P, Barrett AJ and Baici A (eds) Proteinases and tumor invasion. Raven Press, New York, 1980, pp 143–152.

    Google Scholar 

  176. Ladehoff AA: The fibrinolytic activity of tumors of the kidney and bladder. Acta Pathol Microbiol Scand 55: 273–280, 1962.

    Google Scholar 

  177. Naito S, Tanaka K, Kanmori T, Hisano S, Momose S: Establishment of a human renal pelvic cancer cell line producing tissue thromboplastin and plasminogen activator. Urological Res 10: 19–25, 1982.

    Google Scholar 

  178. Wilson EL, Becher MLB, Hoal EG, Dowdle EB: Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Cancer Res 40: 933–938, 1980.

    Google Scholar 

  179. Woolley DE, Tetlow LC, Mooney CJ, Evanson JM: Human collagenase and its extracellular inhibitors in relation to tumor invasiveness. In: Sträuli P, Barrett AJ and Baici A (eds) Proteinases and tumor invasion. Raven Press, New York, 1980, pp 97–113.

    Google Scholar 

  180. Wirl G, Frick J: Collagenase-A marker enzyme in human bladder cancer? Urol Res 7: 103–108, 1979.

    Google Scholar 

  181. Baugh RJ, Schnebli HP: Role and potential therapeutic value of proteinase inhibitors in tissue destruction. In: Sträuli P, Barrett AJ, Baici A (eds) Proteinases and tumor invasion. Raven Press, New York, 1980, pp 157–179.

    Google Scholar 

  182. DiStefano JF, Beck G, Lane B, Zucker S: Role of tumor membrane-bound serine proteases in tumor induced target cytolysis. Cancer Res 42: 207–218, 1982.

    Google Scholar 

  183. Kuettner KE, Pauli BU: Resistance of cartilage to invastion. In: Weiss L and Gilberg HA (eds) Bone metastasis. GK Hall, Boston 1981, p 131.

    Google Scholar 

  184. Kakizoe T, Esunu H, Kawachi T, Sugimura T, Takencki T, Umezawa H: Further studies on the effect of leupeptin, a protease inhibitor, on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl) nitrosamine. JNCI 59: 1503–1508, 1977.

    Google Scholar 

  185. Mareel M, De Bruyne G, De Ridder L: Invasion of malignant cells into 51CR-labeled host tissues in organotypical culture. Oncology 34: 6–9, 1977.

    Google Scholar 

  186. Van Peteghem MC, Mareel MM, De Bruyne GK: Phagocytic capacity of invasive malignant cells in three-dimensional culture. Virchows Arch B Cell Path 34: 193–204, 1980.

    Google Scholar 

  187. De Bruyne G, Mareel M: Immunohistochemistry of invasion in threedimensional culture. Arch Geschwulst-forsch 51: 15–19, 1981.

    Google Scholar 

  188. Sträuli P: A concept of tumor invasion. In: Sträuli P, Barrett AJ, Baici A (eds) Proteinases and tumor invasion. Raven Press, 1980, pp 1–15.

  189. Mareel MM, Kieler J, Bruyneel E, Van Cauwenberge R, Dragonetti C: Invasiveness of malignant ST/a mouse lung cells in vitro. Virchows Arch 38: 101–116, 1981.

    Google Scholar 

  190. Kieler J, Oda Y, Ulrich K, Willumsen BM: Antigenic modifications associated with ‘Spontaneous’ malignant alterations of mouse fibroblasts propagated in vitro. Carlsberg Res Com 49: 293–305, 1984.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Fibiger Institute, Copenhagen Ø, Denmark

    Jørgen v. F. Kieler

Authors
  1. Jørgen v. F. Kieler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kieler, J.v.F. Invasiveness of transformed bladder epithelial cells. Cancer Metast Rev 3, 265–296 (1984). https://doi.org/10.1007/BF00048389

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00048389

Keywords

Search

Navigation